Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Psoriasis Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Psoriasis Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Psoriasis Therapeutics Market, by Molecule Type, 2019-2029 (USD Billion)
1.2.4. Psoriasis Therapeutics Market, by Route of Administration, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Psoriasis Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Psoriasis Therapeutics Market Dynamics
3.1. Psoriasis Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of Psoriasis disease.
3.1.1.2. Rising awareness towards different treatment options available.
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High treatment cost associated with Psoriasis treatment.
3.1.2.2. Health risks associated with medications.
3.1.3. Market Opportunities
3.1.3.1. Rising healthcare infrastructure in emerging economies.
3.1.3.2. Increasing R&D activities in pharmaceuticals sector.
Chapter 4. Global Psoriasis Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Psoriasis Therapeutics Market, by Drug Class
6.1. Market Snapshot
6.2. Global Psoriasis Therapeutics Market by Drug Class, Performance - Potential Analysis
6.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Psoriasis Therapeutics Market, Sub Segment Analysis
6.4.1. TNF Inhibitors
6.4.2. PDE4 Inhibitors
6.4.3. Interleukin Blockers
6.4.4. Others
Chapter 7. Global Psoriasis Therapeutics Market, by Molecule Type
7.1. Market Snapshot
7.2. Global Psoriasis Therapeutics Market by Molecule Type, Performance - Potential Analysis
7.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Molecule Type 2019-2029 (USD Billion)
7.4. Psoriasis Therapeutics Market, Sub Segment Analysis
7.4.1. Biologics
7.4.2. Small Molecules
Chapter 8. Global Psoriasis Therapeutics Market, by Route of Administration
8.1. Market Snapshot
8.2. Global Psoriasis Therapeutics Market by Route of Administration, Performance - Potential Analysis
8.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
8.4. Psoriasis Therapeutics Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
Chapter 9. Global Psoriasis Therapeutics Market, Regional Analysis
9.1. Psoriasis Therapeutics Market, Regional Market Snapshot
9.2. North America Psoriasis Therapeutics Market
9.2.1. U.S. Psoriasis Therapeutics Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Molecule Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Route of Administration breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Psoriasis Therapeutics Market
9.3. Europe Psoriasis Therapeutics Market Snapshot
9.3.1. U.K. Psoriasis Therapeutics Market
9.3.2. Germany Psoriasis Therapeutics Market
9.3.3. France Psoriasis Therapeutics Market
9.3.4. Spain Psoriasis Therapeutics Market
9.3.5. Italy Psoriasis Therapeutics Market
9.3.6. Rest of Europe Psoriasis Therapeutics Market
9.4. Asia-Pacific Psoriasis Therapeutics Market Snapshot
9.4.1. China Psoriasis Therapeutics Market
9.4.2. India Psoriasis Therapeutics Market
9.4.3. Japan Psoriasis Therapeutics Market
9.4.4. Australia Psoriasis Therapeutics Market
9.4.5. South Korea Psoriasis Therapeutics Market
9.4.6. Rest of Asia Pacific Psoriasis Therapeutics Market
9.5. Latin America Psoriasis Therapeutics Market Snapshot
9.5.1. Brazil Psoriasis Therapeutics Market
9.5.2. Mexico Psoriasis Therapeutics Market
9.6. Rest of The World Psoriasis Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Astellas Pharma Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. AstraZeneca plc
10.2.3. Boehringer Ingelheim GmbH
10.2.4. F. Hofffmann-La Roche
10.2.5. GlaxoSmithKline plc
10.2.6. Merck and Co., Inc.
10.2.7. Valeant Pharmaceuticals International, Inc.
10.2.8. Biocon Limited
10.2.9. Eli Lilly and Company
10.2.10. G and W Laboratories Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption